Saleh Alqahtani

Appearances

OBESITY SURGERY AND RISK OF GASTROINTESTINAL MALIGNANCIES IN PATIENTS WITH NON-ALCOHOLIC FATTY LIVER DISEASE AND OBESITY: A MULTICENTER MATCHED COHORT STUDY
Date
May 8, 2023
Background: Transoral outlet reduction endoscopy (TORe) has been shown to be effective in managing weight regain after Roux-en-Y gastric bypass (RYGB), as has the glucagon-like peptide-1 agonist, liraglutide. However, the effect of adjunctive liraglutide after TORe has yet to be assessed…
Presenter
Arunkumar Krishnan
Speakers
Yousaf Hadi
Tinsay Woreta
Saleh Alqahtani
Sarah Shabih
William Hutson
Shyam Thakkar
Shailendra Singh
West Virginia University
CARDIOVASCULAR AND MORTALITY OUTCOMES WITH GLP-1 RECEPTOR AGONISTS VS. OTHER GLUCOSE-LOWERING DRUGS IN PATIENTS WITH NAFLD AND TYPE 2 DIABETES: A NATIONWIDE MULTICENTER MATCHED COHORT STUDY
Date
May 6, 2023
BACKGROUND: Hepatic encephalopathy (HE) is associated with increased mortality, falls, and frequent hospitalizations. Patient reported outcomes (PROs) are useful tools to assess health-related quality of life (HRQOL) measures such as impairment of sleep, cognition, or activity…
Presenter
Arunkumar Krishnan
Speakers
Carolin Schneider
Diptasree Mukherjee
Tinsay Woreta
Saleh Alqahtani